Hypocalcemia Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting hypocalcemia clinical trials across 7 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Hong Kong, Hong Kong, Corbeil-Essonnes, France, Bristol, South West, United Kingdom. Updated daily from ClinicalTrials.gov.


Hypocalcemia Trials at a Glance

8 actively recruiting trials for hypocalcemia are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Hong Kong, Corbeil-Essonnes, and Bristol. Lead sponsors running hypocalcemia studies include Hospital Universitari de Bellvitge, Hôpital NOVO, and Calcilytix Therapeutics, Inc., a BridgeBio company.

Browse hypocalcemia trials by phase

Treatments under study

About Hypocalcemia Clinical Trials

Looking for clinical trials for Hypocalcemia? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypocalcemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypocalcemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2Phase 3

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company28 enrolled6 locationsNCT07080385
Recruiting

Postoperative Hypocalcemia After Thyroidectomy

Thyroid CancerPostoperative ComplicationsThyroid Nodule+2 more
Minia University600 enrolled1 locationNCT07428057
Recruiting
Not Applicable

Comparing PTeye-assisted Versus Conventional Total Thyroidectomy

Total ThyroidectomyHypocalcemiaHypoparathyroidism Post-surgical+1 more
The University of Hong Kong210 enrolled1 locationNCT07416149
Recruiting
Not Applicable

Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function

Iatrogenic Hypocalcemia
Hospital Universitari de Bellvitge394 enrolled2 locationsNCT05573828
Recruiting
Phase 3

Total Post-thyroidectomy Hypocalcemia After Preoperative Cholecalciferol Supplementation

Hypocalcemia
Hôpital NOVO200 enrolled6 locationsNCT04775381
Recruiting
Phase 2

The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia

voice changeHypocalcemia
Tseung Kwan O Hospital, Hong Kong100 enrolled1 locationNCT05732883
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852
Recruiting

Registry for Hypoparathyroidism Wuerzburg

Quality of LifeComorbidities and Coexisting ConditionsMorality+2 more
University of Wuerzburg300 enrolled1 locationNCT05585593